
1034PPhase I study of intraperitoneal TRX-E-002-1 in subjects with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer: Three-month follow-up results of the dose escalation phase
Coward, J, Kichenadasse, G, Harnett, P, Moore, K, Barve, M, Berg, D, Garner, J, Dizon, DVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.042
Date:
October, 2019
Fichier:
PDF, 92 KB
2019